Company profile
Elucid company profile
Based in the Boston biotech and medtech hub, Elucid is focused on improving the accuracy, experience, & cost-effectiveness of cardiovascular diagnostic imaging by leveraging machine learning. Elucid's main product, ElucidVivo, is the first-ever, FDA-cleared, histologically-validated software for evaluating plaque vulnerability from a single CTA to inform risk of event (heart attack or stroke) & treatment selection. Additionally, Elucid works with pharmaceutical companies, providers, and research organizations to provide quantitative image analysis services.
Business identity
- Website
- http://elucid.com
- Contact email
- [email protected]
- Phone number
- 617-329-9487
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 101-250 employees
- Revenue range
- $0-$1M
- Founded
- 2013-01-01, Year
Headquarters
- Headquarters
- Panora, Iowa, United States
- Postal code
- 02111
- Country code
- US
- Continent
- North America